Mentions
Extended reach
Total likes
Video views
AI synopsis
Several posts mention specific results of the study, such as the dramatic reduction in mortality with immediate ablation after ICD shocks, using phrases like "lower mortality" and "reduced risk." This choice of language demonstrates a tone of enthusiasm and urgency around the potential changes in treatment protocols, emphasizing the trial's importance in reshaping perspectives on ventricular tachycardia management.
The majority of discussions show a strong agreement with the study's conclusions, particularly regarding the benefits of ablation.
There is a notable level of interest, as many users are actively seeking and sharing insights about the trial.
While posts exhibit enthusiasm, not all delve deeply into detailed discussions of methodologies or results, reflecting moderate engagement.
Participants perceive the findings of the study as having significant implications for clinical practice, as highlighted by multiple mentions of improved patient outcomes.
Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent shocks in the ablation arm compared with the conventional approach. https://t.co/6BFAGcCqQn https://t.co/BciL9AETDp
#EPeeps @PaoloDellaBell1 VT ablation after first appropriate shock was associated with a reduced risk of the combined death or worsening heart failure hospitalization end point, lower mortality, and fewer ICD shocks. https://t.co/HUxEEP7PzC https://t.co/1oJJuJTW4M
1回目のICD適切作動を経験した症例を2か月以内のアブレーション vs コントロール群に無作為化したPARTITA TrialではABL群はICD適切作動のみでなく死亡＋心不全入院を有意に抑制（HR 0.11）。1st shock後のABLは積極的に勧められそうです。 https://t.co/cCQFNPak0U
These are the 3 favorite studies 2022 chosen by @Phiso_de : PVS in ARVC https://t.co/lOzizAIIp2 PARTITA https://t.co/zddWe4Wb4I ERASE-AF https://t.co/DaAlOJy63h #EHRA_ESC #EHRA_Ecomm @DavidDuncker
Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Check the results from the multicenter randomized PARTITA Trial, just presented at #ACC22 @ACCinTouch @PaoloDellaBell1 https://t.co/zbOdc1ESvC
HRStv hosts discuss the ACC22 highlights, including findings from the PARTITA trial which studied the impact of ventricular tachycardia ablation timing on outcomes for patients with an ICD. Results showed significant…
This week, John Mandrola MD discusses key topics including VT ablation, heart failure care, and three-vessel disease. He highlights findings from the SURVIVE-VT trial, showing that catheter ablation may offer benefits…
This podcast critiques comments on VT ablation while reviewing EHRA presentations. The SURVIVE-VT trial findings suggest catheter ablation shows better outcomes after 24 months compared to antiarrhythmic drugs. Join…
@drjohnm I'm not an electrophysiologist, so I'd love your take on this study... "VT Ablation after appropriate shock associated w/ lower mortality" ... From 8 deaths in control group just 1 had fatal cardiac arrest. Did I miss sth? https://t.co/wN75APk1sq
RT @EHRAPresident:
RT @EHRAPresident:
RT @EHRAPresident:
RT @EHRAPresident:
RT @EHRAPresident:
Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial | Circulation https://t.co/UNM0sm8ogK
RT @EHRAPresident:
RT @EHRAPresident:
RT @EHRAPresident:
RT @EHRAPresident:
These are the 3 favorite studies 2022 chosen by @Phiso_de : PVS in ARVC https://t.co/lOzizAIIp2 PARTITA https://t.co/zddWe4Wb4I ERASE-AF https://t.co/DaAlOJy63h #EHRA_ESC #EHRA_Ecomm @DavidDuncker
#PartitaStudy: #VT #ablation after first appropriate #ICDshock was associated with a reduced risk of the combined death or worsening #HeartFailure hospitalization end point, lower mortality, and fewer ICD shocks https://t.co/YvOSNLaaBZ
1回目のICD適切作動を経験した症例を2か月以内のアブレーション vs コントロール群に無作為化したPARTITA TrialではABL群はICD適切作動のみでなく死亡＋心不全入院を有意に抑制（HR 0.11）。1st shock後のABLは積極的に勧められそうです。 https://t.co/cCQFNPak0U
RT @netta_doc: ✨#ACC22 #LBCT✨ PARTITA Does #AblateVT Timing Affect Prognosis in Patients With an ICD? (Multicenter RCT)
New2Trip: Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients w/ Implantable Cardioverter Defibrillator? Results From Multicenter Randomized PARTITA Trial https://t.co/2KbIsDjHwj
RT @maichi_e: Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator?…
RT @maichi_e: Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator?…
RT @maichi_e: Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator?…
Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial https://t.co/4bLm62yPoX
New2Trip: Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients w/ Implantable Cardioverter Defibrillator? Results From Multicenter Randomized PARTITA Trial https://t.co/2KbIsDjHwj
New2Trip: Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients w/ Implantable Cardioverter Defibrillator? Results From Multicenter Randomized PARTITA Trial https://t.co/2KbIsDjHwj
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @netta_doc: ✨#ACC22 #LBCT✨ PARTITA Does #AblateVT Timing Affect Prognosis in Patients With an ICD? (Multicenter RCT)
Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial https://t.co/YJo96VR2k1
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @netta_doc: ✨#ACC22 #LBCT✨ PARTITA Does #AblateVT Timing Affect Prognosis in Patients With an ICD? (Multicenter RCT)
https://t.co/JxLYUUJUjF
RT @netta_doc: ✨#ACC22 #LBCT✨ PARTITA Does #AblateVT Timing Affect Prognosis in Patients With an ICD? (Multicenter RCT)
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @ArashArya_EP: #EPeeps @PaoloDellaBell1 VT ablation after first appropriate shock was associated with a reduced risk of the combined de…
RT @ArashArya_EP: #EPeeps @PaoloDellaBell1 VT ablation after first appropriate shock was associated with a reduced risk of the combined de…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @ArashArya_EP: #EPeeps @PaoloDellaBell1 VT ablation after first appropriate shock was associated with a reduced risk of the combined de…
Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial | Circulation https://t.co/Wolcb4pTzl
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
RT @ArashArya_EP: #EPeeps @PaoloDellaBell1 VT ablation after first appropriate shock was associated with a reduced risk of the combined de…
RT @joselmerino: Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent…
Should we ablate VTs after the first ICD shock? The PARTITA trial found lower mortality, HF hospitalization and recurrent shocks in the ablation arm compared with the conventional approach. https://t.co/6BFAGcCqQn https://t.co/BciL9AETDp
#EPeeps @PaoloDellaBell1 VT ablation after first appropriate shock was associated with a reduced risk of the combined death or worsening heart failure hospitalization end point, lower mortality, and fewer ICD shocks. https://t.co/HUxEEP7PzC https://t.co/1oJJuJTW4M
RT @Dr_Santangeli: Congrats @PaoloDellaBell1 for this important trial. Early VT ablation slashes death and heart failure risk big time -…
RT @rythmo_sfc:
RT @Dr_Santangeli: Congrats @PaoloDellaBell1 for this important trial. Early VT ablation slashes death and heart failure risk big time -…
Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial https://t.co/l6fRKgX12H
Really interesting and thought provoking paper from ACC 22. Really nice work @PaoloDellaBell1 and colleagues! https://t.co/nl8bCeIq6a
RT @Dr_Santangeli: Congrats @PaoloDellaBell1 for this important trial. Early VT ablation slashes death and heart failure risk big time -…
RT @netta_doc: ✨#ACC22 #LBCT✨ PARTITA Does #AblateVT Timing Affect Prognosis in Patients With an ICD? (Multicenter RCT)
RT @netta_doc: ✨#ACC22 #LBCT✨ PARTITA Does #AblateVT Timing Affect Prognosis in Patients With an ICD? (Multicenter RCT)
RT @Dr_Santangeli: Congrats @PaoloDellaBell1 for this important trial. Early VT ablation slashes death and heart failure risk big time -…
RT @S_NarayanMD: #VT ablation. After appropriate 1st #ICD Rx (PARTITA trial), ablation better than standard therapy
RT @Dr_Santangeli: Congrats @PaoloDellaBell1 for this important trial. Early VT ablation slashes death and heart failure risk big time -…
RT @S_NarayanMD: #VT ablation. After appropriate 1st #ICD Rx (PARTITA trial), ablation better than standard therapy
RT @S_NarayanMD: #VT ablation. After appropriate 1st #ICD Rx (PARTITA trial), ablation better than standard therapy
RT @S_NarayanMD: #VT ablation. After appropriate 1st #ICD Rx (PARTITA trial), ablation better than standard therapy
RT @S_NarayanMD: #VT ablation. After appropriate 1st #ICD Rx (PARTITA trial), ablation better than standard therapy
RT @Dr_Santangeli: Congrats @PaoloDellaBell1 for this important trial. Early VT ablation slashes death and heart failure risk big time -…
RT @Dr_Santangeli: Congrats @PaoloDellaBell1 for this important trial. Early VT ablation slashes death and heart failure risk big time -…
RT @S_NarayanMD: #VT ablation. After appropriate 1st #ICD Rx (PARTITA trial), ablation better than standard therapy
RT @S_NarayanMD: #VT ablation. After appropriate 1st #ICD Rx (PARTITA trial), ablation better than standard therapy
RT @Cardio_delaGuia: ⚡️Ablación temprana taquicardias ventriculares reduce muertes, empeoramiento IC y descargas del DAI con menos episodio…
RT @S_NarayanMD: #VT ablation. After appropriate 1st #ICD Rx (PARTITA trial), ablation better than standard therapy
⚡️Ablación temprana taquicardias ventriculares reduce muertes, empeoramiento IC y descargas del DAI con menos episodios recurrentes de TV. La ablación para prevenir episodios de TV después de una descarga de DAI, cuanto antes, mejor! @CircAHA #PARTITA
RT @S_NarayanMD: #VT ablation. After appropriate 1st #ICD Rx (PARTITA trial), ablation better than standard therapy
Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial https://t.co/pYsokvZVCO Next JC @AllenAmornMD @vijaywantbrar @GirijaBhoite @hajaw0
RT @HSRmasterEP: Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillato…
Impressive results from the randomized PARTITA trial supporting early invasive therapy of #VT in #ICD-carriers.
Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial https://t.co/rtSweaahzA
Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Check the results from the multicenter randomized PARTITA Trial, just presented at #ACC22 @ACCinTouch @PaoloDellaBell1 https://t.co/zbOdc1ESvC
Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial https://t.co/UWwbmE0qRy